CE van der Schoot

1.4k total citations
23 papers, 1.2k citations indexed

About

CE van der Schoot is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, CE van der Schoot has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Genetics and 5 papers in Hematology. Recurrent topics in CE van der Schoot's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Blood disorders and treatments (7 papers) and Immune Response and Inflammation (6 papers). CE van der Schoot is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Blood disorders and treatments (7 papers) and Immune Response and Inflammation (6 papers). CE van der Schoot collaborates with scholars based in Netherlands and Italy. CE van der Schoot's co-authors include AE von dem Borne, Dirk Roos, LA Ginsel, TW Kuijpers, AJ Verhoeven, T. Huizinga, IC Slaper-Cortenbach, RH van Oers, J. Pinkster and JM Kerst and has published in prestigious journals such as Blood, BJOG An International Journal of Obstetrics & Gynaecology and Leukemia.

In The Last Decade

CE van der Schoot

23 papers receiving 1.1k citations

Peers

Countries citing papers authored by CE van der Schoot

Since Specialization

Citations

This map shows the geographic impact of CE van der Schoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CE van der Schoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CE van der Schoot more than expected).

Fields of papers citing papers by CE van der Schoot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CE van der Schoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CE van der Schoot. The network helps show where CE van der Schoot may publish in the future.

Co-authorship network of co-authors of CE van der Schoot

This figure shows the co-authorship network connecting the top 25 collaborators of CE van der Schoot. A scholar is included among the top collaborators of CE van der Schoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CE van der Schoot. CE van der Schoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review 2010 ·BJOG An International Journal of Obstetrics & Gynaecology ·(unknown), (unknown), Leendert Porcelijn, Masja de Haas, CE van der Schoot, Anneke Brand, G.J. Bonsel, Dick Oepkes	85
2	Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy 2001 ·Leukemia ·Válerie de Haas, (unknown), A. von dem Borne, Wilma G. M. Kroes, Henk van den Berg, CE van der Schoot	49
3	Molecular characterization of antigenic polymorphisms (Ond(a) and Mart(a)) of the beta 2 family recognized by human leukocyte alloantisera 1996 ·Blood ·Suat Şimşek, CE van der Schoot, (unknown), Elly Huiskes, Mary Clay, John McCullough, (unknown), David F. Stroncek, AE von dem Borne	44
4	Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells 1995 ·Blood ·(unknown), (unknown), CE van der Schoot, (unknown), (unknown), René A. W. van Lier	9
5	Max(a), a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia 1995 ·Blood ·Patrizia Noris, Suat Şimşek, (unknown), Leendert Porcelijn, Elly Huiskes, (unknown), EF van Leeuwen, CE van der Schoot, AE von dem Borne	1
6	Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody 1994 ·Blood ·(unknown), (unknown), EF van Leeuwen, CE van der Schoot, AE von dem Borne, IC Slaper-Cortenbach	16
7	Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody 1994 ·Blood ·(unknown), (unknown), EF van Leeuwen, CE van der Schoot, AE von dem Borne, IC Slaper-Cortenbach	2
8	Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells 1993 ·Blood ·JM Kerst, JG van de Winkel, (unknown), Masja de Haas, IC Slaper-Cortenbach, (unknown), AE von dem Borne, CE van der Schoot, RH van Oers	71
9	Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells 1993 ·Blood ·JM Kerst, JG van de Winkel, (unknown), Masja de Haas, IC Slaper-Cortenbach, (unknown), AE von dem Borne, CE van der Schoot, RH van Oers	1
10	Expression and release of CD27 in human B-cell malignancies 1993 ·Blood ·(unknown), Steven T. Pals, (unknown), CE van der Schoot, Gerrit Koopman, (unknown), RQ Hintzen, AE von dem Borne, René A. W. van Lier	109
11	Expression and release of CD27 in human B-cell malignancies 1993 ·Blood ·(unknown), Steven T. Pals, (unknown), CE van der Schoot, Gerrit Koopman, (unknown), RQ Hintzen, AE von dem Borne, René A. W. van Lier	3
12	Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way 1993 ·Blood ·JM Kerst, (unknown), IC Slaper-Cortenbach, (unknown), Berend Hooibrink, RH van Oers, AE von dem Borne, CE van der Schoot	4
13	Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression 1993 ·Blood ·H. J. Adriaansen, (unknown), (unknown), CE van der Schoot, (unknown), JJ van Dongen	5
14	Induction of neutrophil FC-gamma receptor I expression can be used as a marker for biologic activity of recombinant interferon-gamma in vivo [letter] 1991 ·Blood ·T. Huizinga, CE van der Schoot, Dirk Roos, Weening Rs	24
15	Induction of neutrophil FC-gamma receptor I expression can be used as a marker for biologic activity of recombinant interferon-gamma in vivo [letter] 1991 ·Blood ·T. Huizinga, CE van der Schoot, Dirk Roos, Weening Rs	37
16	Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation 1991 ·Blood ·TW Kuijpers, (unknown), CE van der Schoot, LA Ginsel, (unknown), Dirk Roos, AJ Verhoeven	320
17	In situ localization by double-labeling immunoelectron microscopy of anti-neutrophil cytoplasmic autoantibodies in neutrophils and monocytes 1990 ·Blood ·Jero Calafat, Roel Goldschmeding, (unknown), Hans Janßen, CE van der Schoot	48
18	Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay 1990 ·Blood ·CE van der Schoot, T. Huizinga, (unknown), (unknown), J. Pinkster, AE von dem Borne	168
19	Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay 1990 ·Blood ·CE van der Schoot, T. Huizinga, (unknown), (unknown), J. Pinkster, AE von dem Borne	3
20	Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation 1989 ·Blood ·CE van der Schoot, Piet Jansen, (unknown), (unknown), AE von dem Borne, LA Aarden, RH van Oers	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact